BioSpace News Archive

Marler Clark, the Nation’s Food Safety Law Firm, commends the United States Public Interest Research Groups (PIRG) research on the food safety system.

Itamar Medical Ltd. (TASE: ITMR), a company that develops, manufactures, and markets non-invasive diagnostic medical devices for sleep apnea with a focus on the cardiology market, today announced that it has entered into definitive agreements for a $11.5 million private placement at a purchase price of NIS 1.1693 per ordinary share of the Company, or $9.55 per American Depositary Share (ADSs), each representing 30 ordinary shares

Medtronic plc (NYSE:MDT) today announced the first patient enrolled in the Embrace TDD (targeted drug delivery) clinical study that will evaluate the use of the SynchroMed™ II intrathecal drug delivery system (“Medtronic pain pump”) as an alternative to oral opioids for patients with chronic intractable non-malignant primary back pain with or without leg pain.

Asceneuron, an emerging leader in the development of orally bioavailable modulators of tau pathology for the treatment of neurodegenerative diseases, today announces the appointment of Peter Van Vlasselaer as Chair of the Board of Directors.

CDISC today announced three new members have joined its Board of Directors. Dr. Pandu Kulkarni, Dr. Hiroshi Masumoto, and Dr. Zhengqing Li each began serving a three-year term at the beginning of the year.

Ironshore Pharmaceuticals (“Ironshore”), a wholly owned subsidiary of Highland Therapeutics Inc. (“Highland”) and a leader in the commercialization of novel treatments for Attention Deficit Hyperactivity Disorder (ADHD), today announced the appointment of Dr. Lewis Warrington to the position of Vice President / Head of Medical Affairs.

The study examined a UV light technology platform deployed by New York-based PurpleSun that can be used for a range of disinfection applications for ORs, patient rooms and other health care settings

Bear Real Estate Advisors announced today that the real estate investment services firm represented Global Medical REIT (NYSE: GMRE) in its acquisition of an approximately 42,000-square-foot, Class A medical office building located in the Los Angeles suburb of Corona, Calif. Global Medical REIT acquired the property for approximately $17 million.

Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial stage biopharmaceutical company focused on saving and improving the lives of pets, today announced a proposed public offering of its common stock.

1 in 15 homes at risk for dangerous levels of radon, which causes lung cancer, the leading cause of cancer deaths